phenotype on a proto-oncogene (Miller et al
as phorbol esters, cell surface antibodies and calcium ionophores (Schuler and Cole, 1988; Expression of many proto-oncogenes, cytokines and 1989) . Whether this results from differential destabilization lymphokines is regulated by targeting their messenger or selective stabilization is not clear, since non-ARERNAs for rapid degradation. Essential signals for associated mRNA stabilizing sequences also exist in the this control are AU-rich elements (AREs) in the 3Ј GM-CSF 3Ј UTR (Iwai et al., 1991) . Other explanations untranslated region (UTR) of these messages. The for differential regulation stem from the discovery that ARE is loosely defined as the five-nucleotide sequence the c-fos and c-myc proto-oncogene mRNAs contain AUUUA embedded in a uracil-rich region. A transadditional destabilizing elements found throughout their acting factor, presumably a protein, binds the ARE and length Chen et al., 1994) . initiates recognition by the destabilization machinery.
Another complex issue is whether ongoing translation Numerous candidate ARE-binding proteins have been is required for destabilization. Early work showed that proposed. We show that a 32 kDa protein in HeLa translational inhibitors stabilized ERG mRNAs, suggesting nuclear extracts characterized previously has RNAa requirement for either a labile protein factor or translation binding specificity that correlates with the activity of of the mRNA body itself (Greenberg et al., 1986) . Several an ARE in directing mRNA decay. Purification and studies support the latter explanation: inhibition of translasubsequent analyses demonstrate that this 32 kDa tion by introducing either a strong stem-loop structure protein is identical to a recently identified member of into the 5Ј UTR (Aharon and Schneider, 1993) or a the Elav-like gene family (ELG) called HuR. The premature stop codon into the open reading frame (ORF) in vitro binding selectivity of HuR is indicative of an (Savant-Bhonsale and Cleveland, 1992) inhibited transla-ARE sequence's ability to destabilize a mRNA in vivo, tion and prevented destabilization. Re-introduction of an suggesting a critical role for HuR in the regulation of internal ribosome entry site downstream of the stem-loop mRNA degradation.
Introduction
a message regardless of location, as long as they were placed 5Ј to the ARE (Curatola et al., 1995) . An iron Post-transcriptional regulation of messenger RNA response element (IRE) in the 5Ј UTR of a mRNA was (mRNA) levels is an important control point in gene used to control intracellular localization and translation; expression. Significant attention has focused on a class of with either the c-fos ARE or GM-CSF ARE in the 3Ј early response genes (ERGs), which code for cytokines, UTR, the message was destabilized only when loaded on lymphokines or proto-oncogenes. Their short-lived polysomes (Winstall et al., 1995) . Conversely, inhibition mRNAs are generally transcribed for a limited time in of translation by introduction of an IRE was reported not response to extracellular stimuli and then rapidly removed to stabilize an mRNA carrying the c-fos ARE in its 3Ј from the cytoplasm by targeted degradation. This UTR (Koeller et al., 1991) . Similarly, translation has been instability is regulated by a cis-acting adenylate-uridylateuncoupled from destabilization for both the c-fos and GMrich element (ARE) found in the 3Ј untranslated region CSF AREs using stem-loop structures in 5Ј UTR (Chen (UTR) of the mRNA (Caput et al., 1986; Shaw and et al., 1995) . Kamen, 1988 ; for reviews, see Belasco and Brawerman, In an effort to explain these apparent contradictions, 1993; Chen and Shyu, 1995) . The initial experimental Shyu and co-workers (Chen and Shyu, 1994; , observation was that a 51-nucleotide sequence transplanted 1995) defined three different classes of destabilizing from the 3Ј UTR of an unstable mRNA (granulocyteelements: AUUUA-lacking elements and AUUUA-conmacrophage colony-stimulating factor, GM-CSF) to the taining elements subdivided into those with scattered 3Ј UTR of a stable message (β-globin) was sufficient to target the stable mRNA for rapid degradation (Shaw and AUUUA motifs (typified by proto-oncogene mRNAs) and those with multiple, overlapping iterations of the AUUUA proteins and showed that it binds specifically in vitro to ARE sequences, similar to other ELAV proteins reported pentanucleotide (typified by growth factors). Division into these three classes was supported by careful examination previously (Levine et al., 1993; Gao et al., 1994) .
Of particular interest to us has been an apparent 32 kDa of the decay kinetics of growth factor and proto-oncogene AUUUA-containing ARE mRNAs, including differences protein identified by Vakalopoulou et al. (1991) in nuclear extracts from HeLa cells. A correlation between UVin poly-A tail removal (Chen et al., 1995) and characterization of a non-AUUUA-containing ARE in the c-jun crosslinking of the protein in vitro and ability to destabilize in vivo was initially established for a small number of proto-oncogene (Peng et al., 1996) . Specific sequences which can serve as destabilizing elements in vivo have ARE sequences. We subsequently demonstrated that this protein also binds three virus-encoded small nuclear RNAs recently been more precisely defined by deletion mutagenesis and construction of artificial AREs. Zubiaga and (snRNAs) which are expressed in marmoset T-cells transformed by Herpesvirus saimiri (Myer et al., 1992) . This co-workers (1995) pared down the c-fos ARE to a minimal destabilizing element and used this information to consuggested that the viral snRNAs may contribute to transformation by sequestering the 32 kDa protein in a stable, struct artificial AREs. Lagnado et al. (1994) adopted a similar strategy starting directly with artificial AREs. nuclear particle and thereby modulating mRNA stability in the cell. Both groups concluded that a single AUUUA motif is insufficient for destabilization, whereas one copy of the Here, we have further characterized the HeLa 32 kDa protein with respect to its ARE-binding specificity. Using nine-nucleotide sequence UUAUUUAUU is weakly destabilizing and two copies provide strong destabilization.
sequences previously tested in vivo, we find that the 32 kDa protein in nuclear extract interacts in vitro only Numerous proteins have been implicated in mRNA destabilization by virtue of their ability to bind the ARE.
with those that serve as effective destabilizing elements in vivo. Even similar sequences which function quite Most of these are in the 30-45 kDa size range. First identified was a three-subunit complex of 44 kDa termed differently in vivo are faithfully distinguished by protein binding in vitro. We have purified the 32 kDa protein and AUBF (AU-rich sequence binding factor; Malter, 1989) . This phosphorylated protein is up-regulated in peripheral identified it as being identical to HuR (Ma et al., 1996) . We show that binding of HuR in vitro to previously blood cells and a T-cell leukemia line upon treatment with phorbol esters or calcium ionophores, consistent with a untested RNAs can predict the ability of these sequences to serve as functional AREs in vivo. Our results argue role in cytokine and lymphokine regulation (Malter and Hong, 1991) ; it also recognizes proto-oncogene AREs that HuR is a component of the mRNA destabilization machinery. (Gillis and Malter, 1991) . Development of an in vitro destabilization system allowed identification and characterization of a fraction which accelerates the decay of
Results
ARE-containing messages. It contains two polypeptides of 37 kDa and 40 kDa called AUF1 (Brewer, 1991) ; a RNA binding specificity of the 32 kDa protein The recent in vivo dissection of ARE sequences (Lagnado cDNA encoding the 37 kDa protein has been cloned and contains two RNA recognition motifs (RRMs) as well Zubiaga et al., 1995) provides a benchmark to which the binding specificity of any protein suspected a glutamine-rich C-terminal domain (Zhang et al., 1993; Ehrenman et al., 1994) . Three activities termed AU-A, to be involved in mRNA decay can be compared. We used two different assay systems to analyze the performance of AU-B and AU-C likewise bind to ARE sequences (Bohjanen et al., 1992) . AU-B and AU-C appear to be the 32 kDa protein (Vakalopoulou et al., 1991; Myer et al., 1992) in binding competition reactions in HeLa structurally related and have specificity for lymphokine and cytokine AREs (Bohjanen et al., 1991) , while AU-A nuclear extract. UV-crosslinking allows direct visualization of proteins bound to a radiolabeled RNA: short-wave (34 kDa) is not selective and appears to shuttle between the nucleus and cytoplasm (Katz et al., 1994) . Two studies (254 nm) light forges a covalent polypeptide-RNA bond, thereby tagging the protein with a radioactive moiety using UV-crosslinking have identified proteins of 82, 71, 66 and 37 kDa (You et al., 1992) as well as 70, 45, 40, which allows detection by autoradiography. Gel retardation experiments, also using radiolabeled RNA, require fewer 38 and 32.5 kDa (Nakamaki et al., 1995) which crosslink to AU-rich sequences from the c-fos and GM-CSF 3Ј manipulations and probably more closely mimic in vivo conditions as a protein must remain stably bound to the UTR, respectively. In the latter study, actinomycin-D treatment depleted the 32.5 kDa protein from the nuclear substrate throughout the assay procedure.
To assess the binding of various sequences to the 32 kDa fraction, yet none of the binding activities was affected by chemicals known to stabilize growth factor mRNAs protein, each was tested for its ability to compete with a readily bound substrate in HeLa cell nuclear extract. The (Nakamaki et al., 1995) . Immunoprecipitation experiments showed that while the 45, 40 and 38 kDa proteins (AUUU) 4 A RNA probe contains four tandemly repeated copies of the AUUUA motif, which is the core of the were crossreactive with anti-AUF1 antibodies, the 40 and 38 kDa proteins were also crossreactive with anti-hnRNP ARE sequence (Caput et al., 1986; Shaw and Kamen, 1988) and has been shown to be an effective destabilizing C antibodies (Nakamaki et al., 1995) . The hnRNP A1 and C proteins had previously been shown to associate with element in vivo (Zubiaga et al., 1995) . The competitor RNAs (Table I) were transcribed in the presence of a AU-rich sequences (Hamilton et al., 1993) . Affinity chromatography using AUUUA multimers led to the trace amount of radioactive nucleotide to facilitate gel purification and quantitation. They were then combined isolation of a protein with hydratase activity (Nakagawa et al., 1995) . Ma and co-workers (1996) cloned HuR, a at 10-, 20-and 50-fold molar excess with the (AUUU) 4 A RNA, which was labeled to very high specific activity 36 kDa member of the elav family of RRM-containing 
Column 1 gives the names of all constructs. The (AUUU) 4 A construct was previously called AUUUA-3Z (Myer and Steitz, 1995) . Column 2 shows the variable portion of the sequence of the RNAs transcribed from the constructs in column 1. AUUUA pentanucleotides are in bold. All transcripts contain GGGCGAAUUC at their 5Ј ends and GUC at their 3Ј ends, as described in Materials and methods. Column 3 gives a qualitative assessment of each RNA's ability to bind the 32 kDa protein (HuR) in competition with the (AUUU) 4 A RNA as assayed by both UV-crosslinking and mobility shift (see Figure 1) . Column 4 is a qualitative assessment of each sequence's ability to function as an ARE in vivo when tested by transient transfection (see Figure 5 ; Lagnado et al., 1994; Zubiaga et al., 1995) . n.d. indicates not done. a See Figure 1 . b Lagnado et al. (1994) . c Zubiaga et al. (1995) . d See Figure 5 . serve as a reliable predictor of that sequence's ability to destabilize in vivo (see below). The three mutants we Effective competition demonstrates that the 32 kDa protein is limiting under the assay conditions. Each of the commade were modifications of the parent (AUUU) 4 A substrate, since very few mutant sequences targeting the core petitor RNAs was then tested (Figure 1 ) and the results summarized in Table I. AUUUA have been investigated. The middle uracil was changed to a guanosine in the (AUGU) 4 A competitor For those sequences examined by Zubiaga et al. (1995) we found a positive correlation between ability to destabil-( Figure 1 , lanes 26-28), while in (AGGU) 4 A both of the first two Us were converted to Gs (lanes 17-19). In ize in vivo and bind the 32 kDa protein in vitro. Especially interesting are the N2 and 7S7 substrates. The N2 RNA (CUUU) 4 C, all of the adenosines were changed to cytosines (lanes 20-22). Of these three mutants, only the contains two copies of the N1 minimal destabilizing sequence (UUAUUUAUU) separated by five nucleotides, (AUGU) 4 A RNA competed effectively for binding to the 32 kDa protein. The other two mutants do not bind and while 7S7 is shorter by only four nucleotides, having the outside two uracils in each repeat unit deleted. In vivo, would be predicted to be non-destabilizing. Underexposure of the native gel ( Figure 1B ) revealed these substrates showed striking differences in their behavior, with N2 being a very active destabilizing element that the shifted complex formed on the (AUUU) 4 A RNA consists of two bands with similar mobility. We explored and 7S7 being inert (see Zubiaga et al., 1995 and Figure 5) . In vitro, the two RNAs show the same striking the possibility that two different shifted complexes happened to co-migrate by directly examining the bound difference: N2 binds the 32 kDa protein very well (lanes 14-16), while 7S7 binding is not detectable (lanes 11-13).
proteins. We separated nuclear extract that had been UVcrosslinked to radiolabeled (AUUU) 4 A RNA (as in the The only one of the six previously tested substrates for which the in vitro binding and in vivo stabilizing results competition reactions) on a native gel and isolated the shifted complex. After RNase treatment to remove excess do not correlate is the N1 RNA (see Table I ). This RNA appears not to bind at all in either competition assay RNA and fractionation on a denaturing SDS gel, we observed two crosslinked proteins: the 32 kDa protein, as (Figure 1 ). N1 was found to be a weak destabilizing element in vivo (Lagnado et al., 1994; Zubiaga et al., well as a 46 kDa protein (data not shown). The larger protein is seen as the second most prominent band in the 1995); its apparent lack of binding in vitro may therefore reflect a very low affinity for the protein that is easily direct crosslinking assay ( Figure 1A ). Further experiments confirmed that the two crosslinking activities and their competed by lesser amounts of the (AUUU) 4 A RNA. This speculation was confirmed by labeling the N1 RNA to corresponding mobility shifts are separable chromato-graphically (data not shown). Therefore, we argue that assay. HeLa cell nuclear extract (15 ml, equivalent to 7.5ϫ10 9 cells) was precipitated with saturated ammonium each protein independently imparts a similar mobility shift to the (AUUU) 4 A RNA, rather than the shifted complex sulfate (final concentration 50%) and the pellet was loaded onto a gel filtration column (Superdex 200, Pharmacia). being a result of both proteins binding simultaneously to the same RNA.
The 32 kDa protein was found in fraction 13 ( Figure 2A , lane 8), which is well included in the column and is Purification of the 32 kDa protein approximately where a 32 kDa monomeric protein would To characterize the 32 kDa protein further, we purified it be expected to elute. It was important to run the column using UV-crosslinking to the (AUUU) 4 A RNA as the at relatively high salt concentration (400 mM NaCl) because at lower salt levels (150 mM) the protein was completely excluded, suggesting its association with large complexes in nuclear extract (data not shown). Fractionation on other sizing columns indicated that such complexes are entirely excluded from Sephacryl S-300 (exclusion limit of 1.5 MDa) and partially in the void volume of an S-500 column (exclusion limit Ͼ8 MDa; data not shown).
Heparin is often useful for the purification of nucleic acid-binding proteins since its polyanionic structure mimics the sugar-phosphate backbone. The sample from the Superdex 200 column was diluted and loaded onto a heparin-Sepharose column. The 32 kDa protein bound and was eluted by a linear salt gradient at~280 mM NaCl ( Figure 2B ). The slightly larger crosslinked species in Figure 2B , fractions 20 and 21, was identified by Western blotting as the hnRNP A1 protein (data not shown). The bulk of all protein, as well as hnRNP A1, eluted at higher salt (320 mM NaCl). A characteristic smaller doublet coeluting with the 32 kDa protein (seen in fractions 14-19) often appeared during purification and is diagnostic for the 32 kDa protein. We believe these peptides to be stable degradation products of the 32 kDa protein.
Fractions containing peak activity from the heparin column ( Figure 2B , fractions 15-18) were collected, dialyzed to lower salt concentration (100 mM NaCl) and pH (6.3), and loaded onto a Mono S column (Pharmacia). Notably, despite the anionic nature of both the heparin and the Mono S resins, the 32 kDa protein would not bind to Mono S at pH 7.9, thereby necessitating prior dialysis. When bound proteins were eluted with a linear salt gradient, crosslinking activity peaked in fractions 24-26 ( Figure 2C ). Western blot analysis identified peaks of the hnRNP A1 and A2 proteins in fractions 19-20 and 15-16, respectively. All fractions were concentrated to Ͻ50 μl and fractionated on a denaturing SDS gel. After the gel was stained with Coomassie blue and destained, the 32 kDa protein was excised ( Figure 2D , lanes 9-11) and subjected to tryptic digestion and amino acid sequencing. Table I ) was assayed by both UV-crosslinking (A) and mobility shift (B). In (A) and (B), lane 1 shows binding in the absence of added specific competitor; all lanes contain 3 μg of yeast RNA as non-specific competitor. Each unlabeled, specific competitor is presented in three lane sets in both panels with the first lane (2, 5, 8, 11, 14, 17, 20, 23 and 26) being a 10-fold molar excess of the indicated competitor, the second lane (3, 6, 9, 12, 15, 18, 21, 24 and 27) being a 20-fold molar excess, and the third lane (lanes 4, 7, 10, 13, 16, 19, 22, 24 and 28) a 50-fold excess. In (A), the mobility of the crosslinked 32 kDa protein in the 12.5% denaturing SDS gel is indicated with an arrow. In (B), the mobilities of the free probe (FP) and shifted complex (C) on the 4% non-denaturing gel are noted.
Purification was started with 150 mg of protein and partial proteolytic digestion analysis. Comparing digestion profiles of similarly sized crosslinked proteins is a very resulted in~2 μg product. Recovery is estimated at 20% based on UV-crosslinking activity (data not shown), sensitive method for determining their relationship. As shown in Figure 3 , the crosslinked material in the final resulting in an~15 000-fold purification.
To confirm that the material in the final purified fraction purified fraction (lanes 5-8) has a digestion profile identical to that of the 32 kDa protein from crude HeLa extract was the same as the 32 kDa protein which crosslinks to the (AUUU) 4 A RNA in HeLa nuclear extract, we performed (lanes 1-4). Thus, we have purified the 32 kDa protein implicated in mRNA destabilization from HeLa cells.
The 32 kDa protein is HuR
Two peptide sequences obtained from the purified 32 kDa protein (TNLIVNYLPQNMTQDELR and VLVDQTTG-LSR) were exact matches to tryptic fragments predicted for a protein sequence found in the database. HuR is a recently described (Ma et al., 1996) member of the elr-A class of the elav-like gene (ELG) family (Good, 1995) . It is expressed ubiquitously and is highly conserved with 92% identity between Xenopus laevis and humans (Ma et al., 1996) . To confirm that HuR is identical to the 32 kDa protein we had purified, we again relied on comparison of the partial proteolytic digestion profiles of the 32 kDa protein from HeLa cells and recombinant HuR. The ORF encoding HuR was amplified from a human placental cDNA library by PCR and cloned into a bacterial expression vector (pet 11b, Novagen). As shown in the Coomassie-stained gel of total bacterial protein ( Figure 4A ), only a single band with a molecular weight of~32 kDa is strongly and specifically produced upon induction with IPTG. In bacterial extracts prepared by sonication, much of the protein is insoluble, but significant quantities of soluble HuR remain (data not shown).
The binding activity of recombinant HuR in bacterial extracts was tested by UV-crosslinking to the (AUUU) 4 A RNA. As shown in Figure 4B , extracts made from bacteria expressing HuR give a strong crosslinking signal (lane 2) of identical mobility to the 32 kDa protein crosslinked in HeLa cell nuclear extract (lane 1). When extracts made from bacteria carrying the parent plasmid with no HuR insert were used, no significant crosslinks were observed (data not shown). Crosslinking of the starting material (NE) and of selected column fractions are shown. The 32 kDa protein is indicated by a line. Fraction 3 is the column void volume and fraction 13 was processed further. (B) The sample from the sizing column was diluted 1:2 with running buffer to a final salt concentration of 133 mM NaCl and loaded on a heparin-Sepharose column. After washing, the proteins were eluted with a linear salt gradient. The load (L), column flowthrough (FT), and selected gradient fractions were assayed. Fractions 15-18 were processed further. The migration of the 32 kDa protein is denoted with a line. (C) After dialysis to a lower pH and salt concentration, the sample was applied to a Mono S column and proteins eluted with a linear 100-500 mM NaCl gradient. The material loaded onto the column (L) and fractions 14-27 were assayed. (D) After concentration, the Mono S fractions were separated on a preparative gel and stained with Coomassie blue. The identities of the 32 kDa protein, hnRNP A1 and hnRNP A2 (as determined by Western blotting) are noted. The most prominent band in fractions 24-26 was excised and submitted for protein sequencing. 1-4) or Mono S-purified material (lanes 5-8) was crosslinked to the [α-32 P]UTP-labeled (AUUU) 4 A RNA and excised from a preparative gel. These gel slices were loaded onto a second, 15% acrylamide/0.1% SDS gel and subjected to increasing amounts of V8 protease before separation.
The definitive comparative proteolysis map is shown in Figure 4C . Crosslinked protein from HeLa cell extract (lanes 1-4) produced a digestion profile identical to that of crosslinked protein from HuR-expressing bacterial extract (lanes 5-8). Additionally, in vitro binding experiments (data not shown) confirmed that the RNA binding specificity of recombinant HuR is identical to that of the human 32 kDa protein originally identified by Vakalopoulou et al. (1991) . NIH 3T3 cells were co-transfected with the plasmid encoding the β-globin mRNA with the ARE, and a control AREs previously shown to be functional [the c-fos ARE, (AUUU) 4 A and N2] are unstable in our transfection system plasmid pEF-BOS-CAT (Zubiaga et al., 1995) , which constitutively expresses the CAT mRNA. After serum with levels below 35% at 7 h post-induction. Likewise, mRNAs shown to be stable (the parent β-globin pBBB starvation, expression of the β-globin mRNA cloned downstream of the c-fos promoter was initiated by addition and 7S7) exhibit RNA levels Ͼ80% after 7.5 h. Additionally, we observe that the activity of N1 is cell type-specific of serum. Cells were collected every 90 min, and the RNA isolated and analyzed by RNase protection (Figure in our hands: it destabilizes in NIH 3T3 cells (see Figure  5 ), but not in mouse L-cells (data not shown). Another 5A). The level of the CAT mRNA was determined at each point and all numbers standardized to this internal control.
explanation for the discrepancy between N1's behavior in the binding (Figure 1 ) and destabilization ( Figure 5 ) assays The data are shown in Figure 5B and summarized in Table  I . The maximum signal in each case was obtained between is that N1 is simply too short for stable binding. The instability conferred by the previously untested 90 min and 3 h; this level was considered as 100%. The peak expression of mRNA at earlier times (1-1.5 h) in sequences correlates with their in vitro binding specificity. Both the (AGGU) 4 A and (CUUU) 4 C RNAs are ineffective previous studies (Lagnado et al., 1994; Zubiaga et al., 1995) can probably be attributed to the cellular response as AREs, with 95% and 91% RNA remaining at the 7.5 h time point respectively ( Figure 5A and B). In contrast, to the different transfection system (lipofectamine) used here. Another difference is that the stable mRNAs are the (AUGU) 4 A sequence clearly destabilizes, with Ͻ61% RNA remaining. Thus, in vitro binding of a RNA to HuR more stable in our system than in previous reports (Lagnado et al., 1994; Zubiaga et al., 1995) .
successfully predicts a sequence's ability to function as an ARE in vivo. As is evident in Figure 5 , control mRNAs which contain All values were scaled to the level obtained from constitutively expressed CAT mRNA which was co-transfected and also analyzed by RNase protection. 100% RNA is arbitrarily assigned to the time point which gave the highest signal. For pB-(CUUU) 4 C, the 3.0-h rather than the 1.5-h time point was used because of the aberrantly low CAT signal for the 1.5-h point. The data obtained in these experiments have been repeated several times.
Discussion
limited to vertebrates since it has not been identified in Drosophilia, despite efforts to do so (Good, 1995) . All Despite the identification of numerous proteins with ELGs contain three RRMs with a characteristic tethering affinity for ARE elements, none has been definitively domain between the second and third RRM (Robinow linked to ARE-mediated destabilization. Without a reliable et Levine et al., 1993; Good, 1995; Ma et al., in vitro assay for mRNA decay, identification of participat -1996) . The human gene products are targets for antibodies ing proteins must rest on the correlation of in vitro binding produced by individuals with autoimmune disorders such with in vivo activity. Here, we have shown that one as paraneoplastic encephalomyelitis and sensory neuronoprotein, the 32 kDa protein identified by Vakalopoulou pathy (Graus et al., 1985; Dalmau et al., 1990) . The human et al. (1991) , has binding specificity for RNAs that gene products Hel-N1/Hel-N2 have been implicated in correlates directly with a sequence's documented ability mRNA destabilization and translation based on its in vitro to serve as a functional ARE in vivo. Furthermore, binding ARE-binding specificity (Levine et al., 1993) . In an effort specificity is a reliable predictor of a previously untested to identify a member of the ELG family which might be RNA's destabilizing activity. By purifying the 32 kDa a participant in destabilization in all tissues, the human protein, we have shown that it is identical to HuR (Ma elr A family member HuR was cloned using degenerate et al. , 1996) .
PCR (Ma et al., 1996) . Gel retardation assays with HuRHuR is a human homologue of the Drosophilia elav GST fusion proteins confirmed that HuR has a binding (embryonic lethal, abnormal vision) gene. Elav was originspecificity consistent with its involvement in ARE-medially identified in a screen designed to identify nervous ated mRNA destabilization (Ma et al., 1996) . system defects and is essential for proper neural develop-
The binding of HuR in HeLa cell extracts was originally ment (Campos et al., 1985; Robinow et al., 1988) .
shown to be inversely correlated with mRNA accumulation Subsequent work has shown several distinct elav-like for a total of eight sequences (Vakalopoulou et al., 1991) . genes (ELGs) in all higher eukaryotes; they have been In this report we extend this correlation to nine additional classified into four groups (elr A-D) based on their sequences. Moreover, we have assayed the binding of sequence similarity and tissue specificity of mRNA expreseach mutant by competition against a single sequence sion (Good, 1995) . The elr D and C genes (human genes [(AUUU) 4 A] instead of direct crosslinking to the mutant HuD and HuC/ple21, respectively) are neuron-specific sequence. This eliminates the possibility that changing the and serve as very early markers for commitment to sequence affects only crosslinking (but not binding) by development into neuronal cells (Marusich and Weston, removal or alteration of a nucleotide that is chemically 1992; Good, 1995). The elr B protein (human gene Helessential for formation of the crosslink. N1/Hel-N2) is expressed in nervous tissue, as well as in
The sequence discrimination of HuR binding is quite testis, ovaries and certain tumor cell lines (Gao et al., striking. The N2 sequence, which contains two non-1994; Good, 1995) . The elr A gene (human gene HuR) is the most widely expressed family member, but may be overlapping copies of UUAUUUAUU, binds well and destabilizes with near wild-type ARE efficiency (see One possible role for HuR which cannot be ruled out by the present data is that HuR is, in fact, a stabilizing Figures 1 and 5; also Zubiaga et al., 1995) . Removing the four outside U-residues from the two copies of factor. In such a model, HuR would bind to the ARE and restrict access of the degradation machinery to the mRNA UUAUUUAUU (7S7) completely eliminates binding and ARE function. In reciprocal experiments, the in vitro in a regulated fashion. This protection would then be antagonized by specific proteins to initiate decay. Thus, binding of three previously untested sequences successfully predicted their in vivo ARE-function. We also deterHuR would bind well to functional AREs and protect them until degradation of such ARE-containing mRNAs mined by competition that HuR does not bind to (AU) 8 A or (AUU) 5 A but does bind (AUUUU) 3 A (data not shown).
was deemed necessary by the cell. HuR would not bind to non-ARE-like sequences, as they would not be Although none of these sequences has been tested in vivo, a sequence similar to the (AUU) 5 A RNA that contains six recognized by the degradation machinery and would thus require no protection. Experiments to distinguish between AUUA repeats was found to be non-functional in vivo, consistent with our binding data (Lagnado et al., 1994) .
HuR as a destabilizing or stabilizing factor are now possible using transfection to modulate the levels of the Given the correlation between HuR binding and destabilization, we predict that the (AUUUU) 3 A sequence should protein within the cell. The demonstration that the 32 kDa protein is identical to HuR, and that this protein is serve as a functional ARE, while the (AU) 8 A should not.
The identification of the 32 kDa protein as HuR should central to mRNA destabilization, will facilitate subsequent development of immunological tools and other reagents help resolve the role of ongoing mRNA translation in destabilization. Originally, an inverse correlation between necessary for molecular dissection of this important aspect of gene regulation. binding of the 32 kDa protein and RNA accumulation was observed for RNA in nuclear, as well as cytoplasmic fractions (Vakalopoulou et al., 1991) . This suggested that
Materials and methods
translation may not be essential for RNA destabilization DNA oligonucleotide synthesis, cloning and transcription and/or that there may be an independent, but related, All plasmids for in vitro transcription of RNAs used in competition or nuclear destabilization pathway. We originally became binding experiments were created identically to the AUUUA-3Z plasmid interested in ARE-containing mRNAs because a group of (Myer and Steitz, 1995) . Complementary oligonucleotides containing an viral small nuclear RNAs (snRNAs) contain ARE-like internal HincII site were cloned into the EcoRI and HindIII sites of the vector pGEM-3Z (Promega). After digestion with HincII and transcription sequences at their 5Ј ends. We showed that the stable by T7 RNA polymerase, the resulting RNA sequence is 5Ј-GGGCGsnRNAs encoded by Herpesvirus saimiri (the HSURs; AAUUC-variable-GUC-3Ј. The variable sequences are listed in Table I .
Herpesvirus saimiri U-RNAs), upon transformation of suggests that HuR may be involved in numerous destabilbp 3149 as measured from the translation start site) followed by various ization pathways, at least some of which clearly do not degradation sequences was inserted directly after the β-globin stop codon. The plasmids pBBB-ARE, pB-N1, pB-N2, pB-7S7, as well require translation.
as the internal control plasmid pEF-BOS-CAT, have been described It is possible that HuR is identical to the AU-A activity previously (Zubiaga et al., 1995) and were the generous gifts of Dr of Bohjanen and co-workers (Bohjanen et al., 1992; Katz J.G.Belasco. The plasmid pBBB was a gift from Dr A.-B.Shyu (Shyu et al., 1994) . AU-A has a molecular weight of~34 kDa, et al., 1989) . Plasmids pB-(AUUU) 4 A, pB-(CUUU) 4 C, pB-(AGGU) 4 A and pB-(AUGU) 4 A were generated in such a way that the N1 (UUAUpredominates in nuclear fractions and binds indiscrimin-UUAUU) sequence in pB-N1 was replaced by each of these four ately to ARE sequences regardless of their origin different 17 base pair sequences. (Bohjanen et al., 1992) . It is not subject to the upThe pGEM-3Z plasmid (Promega) for transcribing the antisense regulation seen for AU-B and AU-C (Bohjanen et al., β-globin RNA contained the globin genomic sequence from nucleotides 1992) and shuttles between the nucleus and cytoplasm 217 to 730 (exon 2 flanked by two introns), while that for antisense CAT contained the sequence from nucleotides 238 to 385 as measured (Katz et al., 1994) , reminiscent of the hnRNP A proteins from the translation start site. After linearization by restriction enzyme (Pinol-Roma and Dreyfuss, 1991) . HuR likewise binds to EcoRI or HindIII (for globin or CAT, respectively) near the 5Ј end of AREs from both GM-CSF and c-fos (Vakalopoulou et al., the sense sequence, the plasmids were transcribed in vitro by SP6 or T7 1991). We speculate that HuR, although having no detect-RNA polymerase (for globin or CAT, respectively) in the presence of [α-32 P]UTP. RNAs were gel-purified as above.
able nuclease activity itself (data not shown), may be a DNA oligonucleotides were synthesized by John Flory at the Keck general targeting factor which specifies any RNA for rapid Foundation Biotechnology Resource Laboratory at Yale University on removal by directing assembly of a degradation complex.
an Applied Biosystems DNA synthesizer. All cloning was performed Selective class-specific regulation could then be imposed according to standard procedures (Maniatis et al., 1982). either by removal of HuR from the mRNA or by directly identities of the numerous ARE-binding proteins identified were prepared essentially as described by Dignam et al. (1983) and modified as in Myer and Steitz (1995) . so far.
Murine NIH 3T3 fibroblasts were passed in Dulbecco's modified induced for 2 h at 37°C in the presence of 1 mM IPTG. Total protein was examined by removing 1 ml samples before induction and after 2 h, Eagle's medium (DMEM; Gibco) with 10% fetal bovine serum (FBS; Gibco).
pelleting each bacterial sample in a microcentrifuge, resuspending the pellet in 100 μl of SDS loading buffer, boiling and fractionating 10 μl on a 12.5% acrylamide/0.1% SDS gel. Proteins were visualized by Binding and competition experiments Binding reactions containing 10 μl of HeLa cell nuclear extract, 3 μg Coomassie blue staining. Bacterial extract was made by pelleting 250 ml of induced bacteria, resuspending and sonicating in 20 ml buffer D. yeast cRNA (Sigma), 0.5 μl 100 mM ATP (Pharmacia), 400 000 c.p.m. (AUUU) 4 A probe labeled to high specific activity and competitor RNA After sonication, the bacteria were subjected to four freeze-thaw cycles and debris was removed by centrifugation at 12 000 g for 10 min. (labeled to low specific activity) at 10-, 20-or 50-fold molar excess in a total of 20 μl were incubated for 15 min at 30°C. From each reaction, Extracts were frozen at -80°C. UV-crosslinking was performed as in the purification assays. 3 μl were removed and loaded directly onto a 4% polyacrylamide/1ϫ TBE non-denaturing gel and electrophoresed at room temperature; gels were dried and exposed to film at room temperature. The remainder of Transfections and RNase protection assays the reaction mixture was crosslinked with 254 nm light for 15 min at Murine NIH 3T3 cells were grown in 100 mm dishes to between 50 4°C, treated with RNase A for 15 min at 37°C, and fractionated on a and 70% confluency and switched to OPTI-MEM I reduced serum 12.5% polyacrylamide/1% SDS gel as described (Myer et al., 1992) . medium (Gibco) for lipofectamine (Gibco) transfection. DNA plasmids (12 μg of the reporter plasmid plus 4 μg of the control pEF-BOS-CAT) Purification of the 32 kDa protein were mixed with 48 μl of lipofectamine reagent in OPTI-MEM I reduced Saturated ammonium sulfate (pH 8.0) was added to 15 ml of HeLa cell serum medium for 45 min and added to cells for overnight incubation. nuclear extract (equivalent to 7.5ϫ10 9 cells) to a final concentration of After recovery in 10% FBS-DMEM for 3-6 h, the transfected cells were 50% and rocked for 30 min at 4°C. Precipitated proteins were removed serum-starved in 0.5% FBS-DMEM for 24 h and then stimulated with by centrifugation at 12 000 r.p.m. for 15 min in an SS-34 rotor (Sorvall).
20% FBS-DMEM as described (Zubiaga et al., 1995) . Following The pellet was resuspended to 4 ml total volume with buffer D [20 mM stimulation, total RNA was collected at various time points using TRIzol HEPES, pH 7.9, 10% glycerol, 0.2 mM EDTA, 0.5 mM DTT, 1 mM reagent (Gibco) and then treated with RQ1 DNase (Promega). The PMSF, 0.05% Thesit (Boehringer-Mannheim)] supplemented with degradation of β-globin mRNA was analyzed by T1 RNase protection 400 mM NaCl and loaded onto a 320-ml Superdex 200 column assays as described (Lee,S.I. et al., 1988) , with the following modifica-(Pharmacia) equilibrated with buffer D ϩ 400 mM NaCl. Fractions tions: for each time point, equal amounts of DNase-treated RNA (20-(10 ml each) were collected starting at 90 ml with the exception of 30 μg) were combined with equal counts of 32 P-labeled anti-β-globin fraction 13, which was 15 ml. 10 μl of each fraction were removed for and anti-CAT probes (2-4ϫ10 5 c.p.m.). The RNA-probe mixture was assay by UV-crosslinking. Reaction mixtures consisted of 10 μl column heated at 85°C for 5 min, incubated at 45°C overnight to allow annealing fraction, 300 000 c.p.m. of [α-32 P]UTP (AUUU) 4 A probe (30 000 c.p.m./ and then digested with T1 RNase (1 unit/10 μg RNA; Calbiochem) at ng), 0.5 μl 100 mM ATP, 5 μg E.coli tRNA and H 2 O to a total volume 30°C for 1 h. The samples were electrophoresed in a 6% polyacrylamide/ of 20 μl. Subsequent crosslinking and processing of reactions was TBE gel, dried and exposed to film. Results were quantitated with a performed exactly as for the competition experiments.
Molecular Dynamics PhosphorImager. Fraction 13 was diluted 1:2 with buffer D to a final volume of 45 ml (NaCl concentration 133 mM) and loaded onto a 1 ml heparin-Sepharose hi-trap column (Pharmacia). After washing with 10 column volumes
